No black box warning on record for Venxxiva

As of the latest FDA labeling reviewed, Venxxiva (TIOPRONIN) does not carry a black box warning. Standard warnings and precautions still apply — see the full Venxxiva medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Proteinuria, including nephrotic syndrome, and membranous nephropathy, has been reported with tiopronin use. Pediatric patients receiving greater than 50 mg/kg of tiopronin per day may be at increased risk for proteinuria. ( 2.1 , 5.1 , 8.4 ) Hypersensitivity reactions have been reported during tiopronin treatment. ( 4 , 5.2 ) 5.1 Proteinuria Proteinuria, including nephr

No black box warning on record for Venxxiva

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Proteinuria, including nephrotic syndrome, and membranous nephropathy, has been reported with tiopronin use. Pediatric patients receiving greater than 50 mg/kg of tiopronin per day may be at increased risk for proteinuria. ( 2.1 , 5.1 , 8.4 ) Hypersensitivity reactions have been reported during tiopronin treatment. ( 4 , 5.2 ) 5.1 Proteinuria Proteinuria, including nephr

Venxxiva Black Box Warning

No black box warning on record for Venxxiva

Other warnings & precautions

Venxxiva Black Box Warning

No black box warning on record for Venxxiva

Other warnings & precautions